Pleomorphic adenomas and mucoepidermoid carcinomas of the breast are underpinned by fusion genes.

Breast cancer

Journal

NPJ breast cancer
ISSN: 2374-4677
Titre abrégé: NPJ Breast Cancer
Pays: United States
ID NLM: 101674891

Informations de publication

Date de publication:
2020
Historique:
received: 19 02 2020
accepted: 08 05 2020
entrez: 19 6 2020
pubmed: 19 6 2020
medline: 19 6 2020
Statut: epublish

Résumé

Primary pleomorphic adenomas (PAs) and mucoepidermoid carcinomas (MECs) of the breast are vanishingly rare. Here we sought to determine whether breast PAs and MECs would be underpinned by the fusion genes reported to occur in their salivary gland counterparts. Our study included three breast PAs and one breast MEC, which were subjected to RNA sequencing (PAs,

Identifiants

pubmed: 32550265
doi: 10.1038/s41523-020-0164-0
pii: 164
pmc: PMC7275089
doi:

Types de publication

Journal Article

Langues

eng

Pagination

20

Subventions

Organisme : NCI NIH HHS
ID : K12 CA184746
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

© The Author(s) 2020.

Déclaration de conflit d'intérêts

Competing interestsJ.S.R.-F. reports receiving personal/consultancy fees from Goldman Sachs and REPARE Therapeutics, membership of the scientific advisory boards of VolitionRx and Page.AI, and ad hoc membership of the scientific advisory boards of Roche Tissue Diagnostics, Ventana Medical Systems, Novartis, Genentech, and InVicro, outside the scope of this study. All other authors declare no conflicts of interest.

Références

Head Neck Pathol. 2013 Jul;7 Suppl 1:S12-9
pubmed: 23821214
Nat Med. 2014 Dec;20(12):1479-84
pubmed: 25384085
Histopathology. 2019 Feb;74(3):463-473
pubmed: 30380176
Genes Chromosomes Cancer. 2008 Mar;47(3):203-6
pubmed: 18050304
Nat Rev Cancer. 2007 Dec;7(12):899-910
pubmed: 18004397
J Clin Pathol. 2003 Jul;56(7):497-506
pubmed: 12835294
J Biochem. 2016 Mar;159(3):287-94
pubmed: 26711237
Nat Commun. 2019 Jan 21;10(1):368
pubmed: 30664630
Nat Struct Mol Biol. 2011 Jul 10;18(8):886-93
pubmed: 21743455
Nat Commun. 2018 Aug 30;9(1):3533
pubmed: 30166553
Genome Res. 2016 Jan;26(1):108-18
pubmed: 26556708
Cancer Res. 1999 Feb 15;59(4):918-23
pubmed: 10029085
J Pathol. 2015 Oct;237(2):166-78
pubmed: 26011570
Nat Biotechnol. 2016 Feb;34(2):155-63
pubmed: 26619011
Science. 2007 Mar 16;315(5818):1576-9
pubmed: 17322030
Histopathology. 2019 Feb;74(3):514-525
pubmed: 30307055
NPJ Breast Cancer. 2016 Nov 16;2:16036
pubmed: 28721389
Nature. 1999 Apr 1;398(6726):431-6
pubmed: 10201374
Cancer Res. 2013 Jul 15;73(14):4289-99
pubmed: 23722545
Breast Care (Basel). 2011 Aug;6(4):293-7
pubmed: 22135628
Genes Chromosomes Cancer. 2006 May;45(5):470-81
pubmed: 16444749
Nat Commun. 2020 Jan 2;11(1):44
pubmed: 31896750
Nat Genet. 2014 Nov;46(11):1166-9
pubmed: 25240283
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
Genes Chromosomes Cancer. 2007 Mar;46(3):215-25
pubmed: 17171686
Cancer Cell. 2002 Nov;2(5):367-76
pubmed: 12450792
Cell Cycle. 2010 Aug 1;9(15):2986-95
pubmed: 20647765
Pathology. 2017 Feb;49(2):215-227
pubmed: 28043647
J Natl Cancer Inst. 2019 Jan 11;:
pubmed: 30649385
NPJ Breast Cancer. 2019 Jan 18;5:6
pubmed: 30675516
Nat Genet. 1997 Feb;15(2):170-4
pubmed: 9020842
Genes Chromosomes Cancer. 2012 Feb;51(2):140-8
pubmed: 22038920
Mod Pathol. 2015 Mar;28(3):340-51
pubmed: 25412848
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18740-4
pubmed: 19841262
Mol Cell. 2003 Aug;12(2):413-23
pubmed: 14536081
Genome Biol. 2011;12(1):R6
pubmed: 21247443
Histopathology. 2019 Dec;75(6):931-937
pubmed: 31361912
Bioinformatics. 2013 Oct 15;29(20):2539-46
pubmed: 23956304
Am J Surg Pathol. 2010 May;34(5):599-608
pubmed: 20410810
Nat Commun. 2018 May 8;9(1):1816
pubmed: 29739933
Am J Surg Pathol. 2005 Oct;29(10):1294-9
pubmed: 16160470
Oncogene. 2006 Oct 5;25(45):6128-32
pubmed: 16652146
Brief Bioinform. 2013 Mar;14(2):178-92
pubmed: 22517427
Nat Genet. 2003 Feb;33(2):208-13
pubmed: 12539049
Am J Surg Pathol. 2009 Jun;33(6):835-43
pubmed: 19092631
NPJ Breast Cancer. 2017 Dec 1;3:48
pubmed: 29214215
J Pathol. 2018 Feb;244(2):143-150
pubmed: 29149504
Am J Surg Pathol. 2019 Mar;43(3):382-388
pubmed: 30489320
PLoS Comput Biol. 2011 May;7(5):e1001138
pubmed: 21625565

Auteurs

Fresia Pareja (F)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA.

Arnaud Da Cruz Paula (A)

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY USA.

Rodrigo Gularte-Mérida (R)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA.
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY USA.

Mahsa Vahdatinia (M)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA.

Anqi Li (A)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA.

Felipe C Geyer (FC)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA.

Edaise M da Silva (EM)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA.

Gouri Nanjangud (G)

Molecular Cytogenetics Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY USA.

Hannah Y Wen (HY)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA.

Zsuzsanna Varga (Z)

Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.

Edi Brogi (E)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA.

Emad A Rakha (EA)

Department of Pathology, Nottingham University, Nottingham, UK.

Britta Weigelt (B)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA.

Jorge S Reis-Filho (JS)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA.

Classifications MeSH